scispace - formally typeset
J

José A. Luchsinger

Researcher at Columbia University

Publications -  267
Citations -  21579

José A. Luchsinger is an academic researcher from Columbia University. The author has contributed to research in topics: Dementia & Risk factor. The author has an hindex of 68, co-authored 231 publications receiving 19153 citations. Previous affiliations of José A. Luchsinger include Columbia University Medical Center & University of California, Davis.

Papers
More filters
Journal ArticleDOI

Regional White Matter Hyperintensity Volume and Cognition Predict Death in a Multiethnic Community Cohort of Older Adults

TL;DR: This study aims to demonstrate the importance of utilizing data from the Health Pathways Study to inform the design and interpretation of clinical practice of smoking cessation practices in the context of substance abuse.
Journal ArticleDOI

ATP-binding cassette protein ABCA7 deficiency impairs sphingomyelin synthesis, cognitive discrimination, and synaptic plasticity in the entorhinal cortex

TL;DR: In this paper , the effects of ABCA7 deficiency in the mouse brain were studied and it was shown that older mice exhibited behavioral deficits in cognitive discrimination in the active place avoidance task.
Journal ArticleDOI

Mediterranean diet and mortality in a US population.

TL;DR: Investigation of the association between MeDi adherence and all-cause mortality in a community-based multiethnic population study of subjects 65 years or older in New York confirmed for US populations what was already known and confirmed for other populations: the beneficial effects of the MeDi seem to be transferable and region.
Journal ArticleDOI

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

Neil H. White, +613 more
- 25 May 2022 - 
TL;DR: Interventions that delay or prevent the onset of type 2 diabetes in overweight/obese subjects with dysglycemia who are at risk for diabetes do not reduce the development of diabetic retinopathy for up to 20 years.